NUS Total Liab from 2010 to 2025
| NUS Stock | USD 7.53 0.97 14.79% |
Total Liabilities | First Reported 1995-12-31 | Previous Quarter 899.8 M | Current Value 876 M | Quarterly Volatility 301.6 M |
Check Nu Skin financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nu Skin's main balance sheet or income statement drivers, such as Depreciation And Amortization of 51.2 M, Interest Expense of 26.4 M or Total Revenue of 1.8 B, as well as many indicators such as Price To Sales Ratio of 0.54, Dividend Yield of 0.076 or PTB Ratio of 1.28. NUS financial statements analysis is a perfect complement when working with Nu Skin Valuation or Volatility modules.
NUS | Total Liab |
Latest Nu Skin's Total Liab Growth Pattern
Below is the plot of the Total Liab of Nu Skin Enterprises over the last few years. It is the total amount of all liabilities that a company has, including both short-term and long-term liabilities. Nu Skin's Total Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Nu Skin's overall financial position and show how it may be relating to other accounts over time.
| Total Liab | 10 Years Trend |
|
Total Liab |
| Timeline |
NUS Total Liab Regression Statistics
| Arithmetic Mean | 783,442,977 | |
| Geometric Mean | 681,574,053 | |
| Coefficient Of Variation | 35.34 | |
| Mean Deviation | 215,801,435 | |
| Median | 893,717,000 | |
| Standard Deviation | 276,851,721 | |
| Sample Variance | 76646.9T | |
| Range | 1.1B | |
| R-Value | 0.66 | |
| Mean Square Error | 46637.3T | |
| R-Squared | 0.43 | |
| Significance | 0.01 | |
| Slope | 38,224,629 | |
| Total Sum of Squares | 1149703.1T |
NUS Total Liab History
About Nu Skin Financial Statements
Nu Skin shareholders use historical fundamental indicators, such as Total Liab, to determine how well the company is positioned to perform in the future. Although Nu Skin investors may analyze each financial statement separately, they are all interrelated. The changes in Nu Skin's assets and liabilities, for example, are also reflected in the revenues and expenses on on Nu Skin's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Total Liabilities | 1.1 B | 586.6 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for NUS Stock Analysis
When running Nu Skin's price analysis, check to measure Nu Skin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nu Skin is operating at the current time. Most of Nu Skin's value examination focuses on studying past and present price action to predict the probability of Nu Skin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nu Skin's price. Additionally, you may evaluate how the addition of Nu Skin to your portfolios can decrease your overall portfolio volatility.